5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.

Pencek RR, Shearer J, Camacho RC, James FD, Lacy DB, Fueger PT, Donahue EP, Snead W, Wasserman DH
Diabetes. 2005 54 (2): 355-60

PMID: 15677492 · DOI:10.2337/diabetes.54.2.355

MeSH Terms (16)

Aminoimidazole Carboxamide Animals Blood Glucose Cyclic AMP Dogs Female Glucose Clamp Technique Glycolysis Hyperinsulinism Infusions, Intravenous Insulin Resistance Liver Male Patch-Clamp Techniques Portal Vein Ribonucleotides

Connections (1)

This publication is referenced by other Labnodes entities:

Links